Immunologic and clinical effects of cytotoxic drugs used in the treatment of rheumatoid arthritis and systemic lupus erythematosus.
Fox
D A
DA
Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor.
McCune
W J
WJ
D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000276:immunology; D001327:Autoimmune Diseases / Q000188:drug therapy / Q000276:immunology*; D001379:Azathioprine / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D001402:B-Lymphocytes / Q000187:drug effects; D003520:Cyclophosphamide / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D007694:Killer Cells, Natural / Q000187:drug effects; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy / Q000276:immunology; D008214:Lymphocytes / Q000187:drug effects; D008727:Methotrexate / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D013601:T-Lymphocytes / Q000187:drug effects
D003520:Cyclophosphamide; D001379:Azathioprine; D008727:Methotrexate